Sponsor pipeline

Qifu Li clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Not charted: 5 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Not applicable
NCT06833437	68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Diagnosing Unilateral Subtype of…	Primary Aldosteronism	Recruiting	2026-02-05
Not specified
NCT06955286	Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism…	Primary Aldosteronism	Recruiting	2026-05-01
NCT06941116	Steroids-Based Screening for Primary Aldosteronism	Primary Aldosteronism	Recruiting	2026-04-28
NCT07512609	Environment, Inflammation and Metabolic Diseases Study	Endocrine Disease	Recruiting	2026-04-06
NCT06635993	Accuracy of 68Ga-Pentixafor PET/CT for Subtypting Diagnosis in Patients With Primary…	Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion	Recruiting	2024-10-10

Get alerts when Qifu Li's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.